Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

Mar 25, 2025 - 07:00

0

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

Related Posts

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025 0

Factbox-What fighter jet programs does the US Air Force have?

Factbox-What fighter jet programs does the US Air Force...

Mar 21, 2025 1

Argentina suspends Telecom's purchase of Telefonica unit

Argentina suspends Telecom's purchase of Telefonica unit

Mar 21, 2025 1

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025 0

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025 0

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025 0